Moyle, GJ, Orkin, C, Fisher, M, Dhar, J, Anderson, J, Wilkins, E, Ewan, J, Ebrahimi, R, Wang, H, Ainsworth, J, Waters, A, Morumba, L, Brook, G, Chikohora, M, Hay, P, Adebiyi, A, Cockerill, M, Ndoro, M, Johnson, M, Carroll, A, Turner, F, Moyle, G, Fletcher, C, Osorio, J, Orkin, C, Hand, J, Desouza, C, Fisher, M, Perry, N, Maher, T, Bray, A, De Burgh Thomas, A, Bunting, M, Jones, L, White, D, Groves, J
, Ross, J, Brown, L, Hood, K, Dhar, J, Johnson, S, Morgan, E, Hewart, R, Ong, E, Wilkins, E, Stockwell, E, Robertson, A, Leen, C, Morris, S, Ellis, L, Maw, R, McKernan, S, Herath, DC, Ewan, J, Hui Wang, M & Ebrahimi, R 2015, '
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals',
PLoS ONE, vol. 10, no. 2, e0116297.
https://doi.org/10.1371/journal.pone.0116297